Pharmaceutical

Alvotech and Dr Reddy’s partner to commercialise AVT03

Alvotech has entered into a collaboration with Dr. Reddy's Laboratories for the commercialisation of AVT03 in the US, Europe and the UK.

May 23, 2024 - 04:00
Alvotech and Dr Reddy’s partner to commercialise AVT03
Alvotech has entered into a collaboration with Dr. Reddy's Laboratories for the commercialisation of AVT03 in the US, Europe and the UK.
Read the original article

Tags:

Previous Article

Genmab acquires biotechnology company ProfoundBio in $1.8bn deal

Next Article

AltruBio secures $225m for immune checkpoint programme development

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Ikena further sheds staff and pipeline in bid to maximise value

Ikena further sheds staff and pipeline in bid to maximi...

May 31, 2024

AbbVie and Richter partner for neuropsychiatric treatments

AbbVie and Richter partner for neuropsychiatric treatments

Oct 26, 2024

STAT+: Big Health acquires Limbix, maker of mental health app for depression in adolescents

STAT+: Big Health acquires Limbix, maker of mental heal...

Jul 14, 2023